Literature DB >> 9233801

A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity.

X H Feng1, R Derynck.   

Abstract

Transforming growth factor-beta (TGF-beta) signals through a heteromeric complex of related type I and type II serine/threonine kinase receptors. In Mv1Lu cells the type I receptor TbetaRI mediates TGF-beta-induced gene expression and growth inhibition, while the closely related type I receptors Tsk7L and TSR1 are inactive in these responses. Using chimeras between TbetaRI and Tsk7L or TSR1, we have defined the structural requirements for TGF-beta signaling by TbetaRI. The extracellular/transmembrane or cytoplasmic domains of TbetaRI and Tsk7L were functionally not equivalent. The juxtamembrane domain, including the GS motif, and most regions in the kinase domain can functionally substitute for each other, but the alphaC-beta4-beta5 region from kinase subdomains III to V conferred a distinct signaling ability. Replacement of this sequence in TbetaRI by the corresponding domain of Tsk7L inactivated TGF-beta signaling, whereas its introduction into Tsk7L conferred TGF-beta signaling. The differential signaling associated with this region was narrowed down to a sequence of eight amino acids, the L45 loop, which is exposed in the three-dimensional kinase structure and diverges highly between TbetaRI and Tsk7L or TSR1. Replacement of the L45 sequence in Tsk7L with that of TbetaRI conferred TGF-beta responsiveness to the Tsk7L cytoplasmic domain in Mv1Lu cells. Thus, the L45 sequence between kinase subdomains IV and V specifies TGF-beta responsiveness of the type I receptor.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9233801      PMCID: PMC1170015          DOI: 10.1093/emboj/16.13.3912

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  38 in total

1.  Type I receptors specify growth-inhibitory and transcriptional responses to transforming growth factor beta and activin.

Authors:  J Cárcamo; F M Weis; F Ventura; R Wieser; J L Wrana; L Attisano; J Massagué
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

2.  Formation of hetero-oligomeric complexes of type I and type II receptors for transforming growth factor-beta.

Authors:  H Yamashita; P ten Dijke; P Franzén; K Miyazono; C H Heldin
Journal:  J Biol Chem       Date:  1994-08-05       Impact factor: 5.157

3.  Heteromeric and homomeric interactions correlate with signaling activity and functional cooperativity of Smad3 and Smad4/DPC4.

Authors:  R Y Wu; Y Zhang; X H Feng; R Derynck
Journal:  Mol Cell Biol       Date:  1997-05       Impact factor: 4.272

4.  A single heteromeric receptor complex is sufficient to mediate biological effects of transforming growth factor-beta ligands.

Authors:  C H Bassing; D J Howe; P R Segarini; P K Donahoe; X F Wang
Journal:  J Biol Chem       Date:  1994-05-27       Impact factor: 5.157

5.  A transforming growth factor beta type I receptor that signals to activate gene expression.

Authors:  C H Bassing; J M Yingling; D J Howe; T Wang; W W He; M L Gustafson; P Shah; P K Donahoe; X F Wang
Journal:  Science       Date:  1994-01-07       Impact factor: 47.728

6.  Characterization of type I receptors for transforming growth factor-beta and activin.

Authors:  P ten Dijke; H Yamashita; H Ichijo; P Franzén; M Laiho; K Miyazono; C H Heldin
Journal:  Science       Date:  1994-04-01       Impact factor: 47.728

7.  Mechanism of activation of the TGF-beta receptor.

Authors:  J L Wrana; L Attisano; R Wieser; F Ventura; J Massagué
Journal:  Nature       Date:  1994-08-04       Impact factor: 49.962

8.  Cloning of a TGF beta type I receptor that forms a heteromeric complex with the TGF beta type II receptor.

Authors:  P Franzén; P ten Dijke; H Ichijo; H Yamashita; P Schulz; C H Heldin; K Miyazono
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

9.  Crystal structure of cyclin-dependent kinase 2.

Authors:  H L De Bondt; J Rosenblatt; J Jancarik; H D Jones; D O Morgan; S H Kim
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

10.  Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.

Authors:  P ten Dijke; H Yamashita; T K Sampath; A H Reddi; M Estevez; D L Riddle; H Ichijo; C H Heldin; K Miyazono
Journal:  J Biol Chem       Date:  1994-06-24       Impact factor: 5.157

View more
  43 in total

Review 1.  Transcriptional control by the TGF-beta/Smad signaling system.

Authors:  J Massagué; D Wotton
Journal:  EMBO J       Date:  2000-04-17       Impact factor: 11.598

2.  TGF-beta receptor-activated p38 MAP kinase mediates Smad-independent TGF-beta responses.

Authors:  Li Yu; Mindy C Hébert; Ying E Zhang
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

3.  Coated pit-mediated endocytosis of the type I transforming growth factor-β (TGF-β) receptor depends on a di-leucine family signal and is not required for signaling.

Authors:  Keren E Shapira; Avner Gross; Marcelo Ehrlich; Yoav I Henis
Journal:  J Biol Chem       Date:  2012-06-15       Impact factor: 5.157

4.  Smad7 inhibits transforming growth factor-beta family type i receptors through two distinct modes of interaction.

Authors:  Yuto Kamiya; Kohei Miyazono; Keiji Miyazawa
Journal:  J Biol Chem       Date:  2010-07-27       Impact factor: 5.157

5.  Determinants of specificity in TGF-beta signal transduction.

Authors:  Y G Chen; A Hata; R S Lo; D Wotton; Y Shi; N Pavletich; J Massagué
Journal:  Genes Dev       Date:  1998-07-15       Impact factor: 11.361

6.  Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors.

Authors:  M Kawabata; H Inoue; A Hanyu; T Imamura; K Miyazono
Journal:  EMBO J       Date:  1998-07-15       Impact factor: 11.598

Review 7.  Specificity, versatility, and control of TGF-β family signaling.

Authors:  Rik Derynck; Erine H Budi
Journal:  Sci Signal       Date:  2019-02-26       Impact factor: 8.192

8.  Nuclear translocation of type I transforming growth factor β receptor confers a novel function in RNA processing.

Authors:  Manasa Chandra; Shengbing Zang; Haiqing Li; Lisa J Zimmerman; Jackson Champer; Akihiro Tsuyada; Amy Chow; Weiying Zhou; Yang Yu; Harry Gao; Xiubao Ren; Ren-Jang Lin; Shizhen Emily Wang
Journal:  Mol Cell Biol       Date:  2012-04-02       Impact factor: 4.272

9.  Bone morphogenetic protein 2 signals via BMPR1A to regulate murine follicle-stimulating hormone beta subunit transcription.

Authors:  Catherine C Ho; Daniel J Bernard
Journal:  Biol Reprod       Date:  2009-02-11       Impact factor: 4.285

Review 10.  TGF-β Signaling from Receptors to Smads.

Authors:  Akiko Hata; Ye-Guang Chen
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.